Background: Heterogeneous findings have been reported in studies of basal ganglia volumes in schizophrenia patients as compared to healthy controls. The basal ganglia contain dopamine receptors that are known to be involved in schizophrenia pathology and to be vulnerable to pre-and perinatal hypoxic insults. Altered volumes of other brain structures (e.g. hippocampus and lateral ventricles) have been reported in schizophrenia patients with a history of obstetric complications (OCs). This is the first study to explore if there is a relationship between OCs and basal ganglia volume in schizophrenia. Methods: Thorough clinical investigation (including information on medication) of 54 schizophrenia patients and 54 healthy control subjects was undertaken. MR images were obtained on a 1.5 T scanner, and volumes of nucleus caudatus, globus pallidum, putamen, and nucleus accumbens were quantified automatically. Information on OCs was blindly collected from original birth records. Results: Unadjusted estimates demonstrated a relationship between increasing number of OCs and larger volume of nucleus accumbens in schizophrenia patients and healthy controls. No statistically significant relationships were found between OCs and the basal ganglia volumes when controlled for intracranial volume, age, and multiple comparisons. There were no effects of typical versus atypical medication on the basal ganglia volumes. The patients with schizophrenia had larger globus pallidum volumes as compared to healthy controls, but there were no case-control differences for accumbens, putamen, or caudate volumes. Conclusion: The present results do not support the hypothesis that OCs are related to alterations in basal ganglia volume in chronic schizophrenia.
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Introduction
Subtle anatomical brain abnormalities have been repeatedly reported from magnetic resonance imaging (MRI) studies of schizophrenia patients (Honea et al., 2005; Shenton et al., 2001; Steen et al., 2006) . Whereas larger lateral ventricles, smaller hippocampi and thinner cortices are relatively consistently reported, findings from studies of the basal ganglia display more heterogeneous results (Ballmaier et al., 2008; Brandt and Bonelli, 2008; Mamah et al., 2007; Tamagaki et al., 2005) .
The basal ganglia structures (putamen, globus pallidum, nucleus caudatus, and nucleus accumbens) are of particular interest in schizophrenia as they contain a high number of dopamine receptors. Disturbed dopamine metabolism is hypothesized to be a core feature in schizophrenia (Howes and Kapur, 2009 ). Use of typical antipsychotic medication (acting on dopamine D2 receptors, abundant in the basal ganglia structures) has been demonstrated to cause reversible alterations in basal ganglia volume (Corson et al., 1999; Lang et al., 2004) . However, diverging findings from schizophrenia case-control studies suggest that other factors, such as illness progression (Tanskanen et al., in press; van Haren et al., 2007; Wang et al., 2008 ), genetic variation (Rajarethinam et al., 2007 , or neurodevelopmental disturbances (Glenthoj et al., 2007) , may also influence basal ganglia volume.
Disturbances of neuronal development have been hypothesized to be of aetiological importance in schizophrenia (Fatemi and Folsom, 2009; Marenco and Weinberger, 2000) . A history of obstetric complications (OCs), i.e. adverse events occurring pre-, peri-, or postnatally, which often imply foetal hypoxia, has been related to increased risk of schizophrenia (Cannon et al., 2002a; Dalman et al., 2001; Geddes et al., 1999; Hultman et al., 1999) , younger age at onset of illness (Verdoux et al., 1997) , and more severe cognitive deficits (Brown et al., 2009; Ellman et al., 2009) . Several studies have shown
